SkylineDx Appoints Oncologist as Acting as Chief Medical Officer

19-Feb-2015 - Netherlands

SkylineDx announced the appointment of Saad Usmani, MD, FACP, as their acting Chief Medical Officer.  Dr. Usmani is currently the Director of Clinical Research (Hematologic Malignancies) and Director of Plasma Cell Disorders at Carolinas HealthCare System’s Levine Cancer Institute in Charlotte, NC.
 
In his role Dr. Usmani will be a key member of the executive team of the company. He will lead the overall clinical vision for the company and provide clinical direction to the scientific and commercial organizations. He will also provide leadership to the organization, interact with the Scientific Advisory Board of the company, and interface with key oncology thought leaders. He will also consult with the company to develop their clinical trials and reimbursement strategies.

Prior to joining Levine Cancer Institute, Dr. Usmani was the Director of Developmental Therapeutics at the University of Arkansas where he led clinical and translational investigations using novel compounds. He has published numerous articles published in peer-reviewed journals and holds leadership positions in several medical associations.



 

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances